Global Animal Vaccine Market Report and Forecast 2023-2031

The global animal vaccine market value was USD 10.5 billion in 2022, driven by the increasing demand for animal-derived products across the globe. The market size is anticipated to grow at a CAGR of 7% during the forecast period of 2023-2031 to achieve a value of USD 19.2 billion by 2031.

Animal Vaccine: Introduction

Animal vaccines are critical tools in veterinary medicine for preventing and controlling infectious diseases in various animal species. These vaccines are designed to stimulate an immune response in animals, helping them develop immunity against specific pathogens.

The introduction of animal vaccines has significantly contributed to the improvement of animal health and welfare, as well as the prevention of zoonotic diseases that can be transmitted from animals to humans. Vaccination plays a vital role in reducing the prevalence and severity of infectious diseases, minimizing the economic losses associated with disease outbreaks, and promoting sustainable livestock production.

Key Trends in the Global Animal Vaccine Market

Key trends in the animal vaccine market include the development of new and improved vaccines with enhanced efficacy, safety, and duration of protection. There is a growing emphasis on the use of novel vaccine technologies, such as recombinant vaccines, subunit vaccines, and vectored vaccines, which offer advantages such as better target specificity and reduced side effects.

Another trend is the increasing focus on vaccines for emerging and re-emerging diseases, as well as the expansion of vaccination programs for companion animals, including dogs and cats. This is driven by the rising pet ownership rates and the growing awareness of the importance of preventive healthcare in companion animals.

Additionally, there is a growing demand for vaccines that meet the requirements of specific production systems, such as organic farming or antibiotic-free production. This reflects the increasing consumer preference for sustainable and ethically produced animal products.

Overall, the animal vaccine market is witnessing advancements in vaccine technology, the development of vaccines for new and emerging diseases, and the expansion of vaccination programs. These trends are aimed at improving animal health, reducing disease transmission, and ensuring the safety and quality of animal-derived products.

Global Animal Vaccine Market Segmentations

Market Breakup by Animal Type

• Livestock
• Swine
• Poultry
• Companion Animals
• Others

Market Breakup by Technology

• Inactive Vaccine
• Live Attenuated Vaccine
• Toxoid Vaccine
• Recombinant Vaccine
• Others

Market Breakup by Diseases

• Foot and Mouth Diseases
• New Castle Disease
• Infectious Bronchitis
• Infectious Bursal Disease
• Fowl Pox
• Rabies
• Others

Market Breakup by Route of Administration

• Subcutaneous
• Intramuscular
• Intraocular
• Oral
• Others

Market Breakup by Distribution Channel

• Veterinary Hospitals
• Veterinary Clinics
• Pharmacies
• Others

Market Breakup by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Global Animal Vaccine Market Scenario

The animal vaccine market is a vital sector within the veterinary industry, playing a crucial role in safeguarding the health and well-being of animals. Animal vaccines are essential tools for preventing and controlling infectious diseases, improving animal productivity, and ensuring food safety.

In recent years, the market for animal vaccines has witnessed significant growth due to various factors. One of the key drivers is the increasing demand for animal-derived products, such as meat, milk, and eggs, which has led to a greater focus on disease prevention and control in livestock and poultry. Additionally, the rise in pet ownership and the growing awareness of preventive healthcare in companion animals have fueled the demand for vaccines in the companion animal segment.

The market is characterized by a wide range of vaccine types, including live attenuated vaccines, inactivated vaccines, subunit vaccines, and DNA vaccines, each designed to address specific disease threats. Manufacturers are continuously investing in research and development to develop innovative and more effective vaccines, incorporating advancements in vaccine technology, such as adjuvants and delivery systems, to enhance immune responses.

Geographically, the market for animal vaccines is witnessing substantial growth in emerging economies, such as India, China, and Brazil, due to the increasing livestock population and rising disposable incomes. Additionally, stringent regulations and guidelines by government and regulatory bodies to ensure animal welfare and food safety have also contributed to the market's expansion.

Global Animal Vaccine Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Zoetis, Inc
• Boehringer Ingelheim International GmbH
• Elanco Animal Health Incorporated
• Merck & Co., Inc
• Ceva Sante Animale SA
• Bayer AG
• Virbac SA
• Neogen Corporation
• ImmuCell Corporation
• Covetrus, Inc

*The publisher always strives to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.